How Wegovy and Mounjaro Doses Compare in UK Trials
Understanding Wegovy vs Mounjaro Equivalent Doses for UK Weight Loss
When comparing Wegovy and Mounjaro equivalent doses, it's essential to understand that these aren't direct dose-for-dose equivalents due to their different active ingredients and mechanisms. Wegovy contains semaglutide (a GLP-1 receptor agonist), whilst Mounjaro contains tirzepatide (a dual GIP and GLP-1 receptor agonist). Both prescription-only medicines have demonstrated significant weight loss results in their respective clinical trials, though the studies used different populations and endpoints, making direct comparison of percentages inappropriate.
The dosing schedules for Wegovy and Mounjaro follow structured escalation patterns designed to minimise side effects whilst maximising efficacy. Wegovy starts at 0.25mg weekly, escalating monthly through 0.5mg, 1mg, 1.7mg, to a maintenance dose of 2.4mg. Mounjaro begins at 2.5mg weekly, increasing every four weeks through 5mg, 7.5mg, 10mg, to a maximum of 15mg. Understanding these Wegovy Mounjaro equivalent doses helps patients and prescribers choose the most appropriate treatment pathway.
UK Pricing Structure: Wegovy and Mounjaro Dose Costs
EverydayMeds provides transparent pricing for both Wegovy and Mounjaro equivalent doses without hidden fees or subscription traps. Wegovy pricing starts with our 0.25mg starter dose at £79.99, progressing to 0.5mg at £94.99, 1mg at £99.99, 1.7mg at £139.99, and maintenance 2.4mg at £209.99. Our Getting Started bundles offer convenience for dose progression, such as the Intro Duo (0.25mg & 0.5mg) for £169.99 or the Progress Trio (0.5mg, 1mg & 1.7mg) for £369.99. New customers apply discount code FIRST40 at checkout, whilst returning customers use DOSE25.
When evaluating Wegovy Mounjaro equivalent doses from a cost perspective, both treatments represent significant investments in your health journey. Our bundle options provide convenience rather than savings, ensuring uninterrupted supply during your treatment progression. The Ultimate Stability Trio offers three months of 2.4mg maintenance supply for £649.99, ideal for patients who have reached their optimal dose. All orders include next-day cold-chain delivery and comprehensive prescriber support throughout your treatment journey.
Clinical Evidence: STEP Trial Results for Wegovy Doses
In clinical trials, patients taking Wegovy alongside diet and exercise achieved remarkable weight loss results across the STEP programme. The landmark STEP 1 trial showed participants achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). STEP 3 demonstrated even higher results of approximately 16% when Wegovy was combined with intensive behavioural therapy.
Long-term data from STEP 5 revealed sustained weight loss of approximately 15.2% over two years, whilst the SELECT cardiovascular outcomes trial showed a 20% reduction in major cardiovascular events. These Wegovy dose-response studies provide robust evidence for the medication's efficacy when used alongside reduced-calorie diet and increased physical activity, though individual results may vary.
How Wegovy Works: GLP-1 Mechanism Behind Weight Loss
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural fullness hormone produced in your intestines. This mechanism reduces appetite and promotes feelings of fullness after smaller meals, potentially helping you consume fewer calories without the constant hunger associated with traditional dieting. The medication works on brain appetite centres, particularly in the hypothalamus, where it may reduce food cravings and the psychological drive to eat. Unlike simple appetite suppressants, Wegovy's GLP-1 action also slows gastric emptying, helping food stay in your stomach longer and contributing to sustained satiety. The weekly injection provides consistent medication levels, supporting appetite regulation throughout your weight management journey.
Ordering Process: From Assessment to Delivery
Getting started with either Wegovy or Mounjaro equivalent doses through EverydayMeds involves a streamlined three-step process designed for convenience and clinical safety. Our three-minute online clinical assessment captures essential medical history, current medications, and weight management goals to help prescribers determine the most appropriate treatment option. Qualified prescribers review your assessment within three working days (or 24 hours with express service) and may request additional information if needed. Once approved, your medication ships via next-day cold-chain delivery in temperature-controlled packaging, ensuring the injection maintains its efficacy from our GPhC-registered pharmacy directly to your door. Our team provides ongoing support throughout your treatment, with easy reordering and dose progression guidance as your needs evolve.
Storage and Practical Considerations for Treatment Success
Both Wegovy and Mounjaro require refrigerated storage at 2-8°C before first use, but Wegovy offers a practical advantage with six weeks of room temperature stability below 30°C once removed from the fridge. This compares favourably to Mounjaro's 21-day room temperature limit, making Wegovy more convenient for travel or temporary storage situations. Wegovy uses Novo Nordisk's FlexTouch pen system, designed for easy self-injection with dose escalation clearly marked on each pen. The dose escalation schedule cannot be skipped - patients must progress through each dose level to minimise side effects and optimise treatment outcomes. Proper injection technique and rotating injection sites (thigh, upper arm, or abdomen) help ensure consistent absorption and reduce injection site reactions.
Comparing Wegovy Mounjaro Equivalent Doses: Mechanism Differences
The fundamental difference between Wegovy and Mounjaro lies in their receptor targeting, which influences how equivalent doses affect weight loss mechanisms. Wegovy targets only GLP-1 receptors, whilst Mounjaro activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptors simultaneously. This dual action may provide different metabolic effects, though both medications require prescription and cannot be directly compared without clinical context. Your prescriber will consider factors like medical history, current medications, and individual response when determining which treatment option suits your needs.
When discussing Wegovy Mounjaro equivalent doses with your prescriber, remember that both treatments have shown significant efficacy in their respective clinical programmes. The choice between them often depends on individual tolerance, medical history, and practical factors like storage requirements or injection frequency preferences. Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which treatment aligns with your weight management goals and lifestyle requirements.
Complete Your Weight Loss Journey: Next Steps
Starting your weight management journey with either Wegovy or understanding Mounjaro equivalent doses begins with our comprehensive online assessment available 24/7. Use discount code FIRST40 as a new customer or DOSE25 for returning patients to access our transparent pricing structure. Our clinical team, operating under GPhC registration #9012878, ensures every prescription meets UK safety standards whilst providing the support you need for successful long-term weight management. Remember that both treatments work best alongside a reduced-calorie diet and increased physical activity, and our prescribers can guide you towards additional resources for comprehensive lifestyle support. Visit https://everydaymeds.co.uk/collections/wegovy to begin your assessment and take the first step towards evidence-based weight management with the convenience of nationwide delivery.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
